Enterprise AI Platform for Pharmaceuticals & Life Sciences

Cost allocation is the feature that gets a platform funded. The moment finance can see spend by team and by feature, the conversation changes entirely.

In pharmaceuticals & life sciences, GxP validation means every system change needs documented evidence before it reaches production. That single fact reshapes how enterprise ai platform has to be built here, the guardrails, the approval points and the evidence trail are design inputs rather than things bolted on before go-live.

The workload we are most often asked to take on first is regulatory dossier assembly, usually integrated against QMS. Integration comes before intelligence. A model that cannot reach your systems of record is a demo with good manners.

Deployed across regulated and unregulated sectors, with audit trails where the regulator expects them. You own the code, the models where they are open-weight, and the documentation to run it without us.